Sanofi India Ltd. announced that it has entered into a marketing and distribution agreement with Emcure Pharmaceuticals for its oncology portfolio in India.
Under the agreement terms, while Sanofi will continue to own its oncology range, comprising 4 brands namely Taxotere, Jevtana, Fludara and Fasturtec, Emcure will market and distribute these brands through its Specialty Unit.
Commenting on the partnership, Shailesh Ayyangar, Vice President -South Asia and Managing Director -Sanofi India and Sanofi -Synthelabo (India) Ltd. said, “Sanofi is highly committed to the field of Oncology.
Help employers find you! Check out all the jobs and post your resume.
